SYRE
Spyre Therapeutics Inc.
Latest News for SYRE
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CG Oncology, Inc. (CGON) and Spyre Therapeutics (SYR......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Spyre Therapeutics yesterday and set a price target of $103.00. According to TipRank......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mereo Biopharma Group Plc (MREO), DocGo (DCGO) and S......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Spyre Therapeutics yesterday and set a price target of $103.00. Slutsky covers the H......
In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Spyre Therapeutics, with a price target of $95.00. According to ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and uniQure (QURE) with bu......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Spyre Therapeutics (SYRE), AxoGen (AXGN) and Wave Li......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $73.65 | -0.5% | 478.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |